925427-31-2

Upstream product

• 925427-24-3 ethyl 4-chloro-1-methyl-1H-imidazo[4,5-c]pyridine-7-carboxylate 
• 108-43-0 3-monochlorophenol 
• 154012-15-4 ethyl 2,4-dichloro-3-nitropyridine-5-carboxylate 
• 925427-23-2 ethyl 5-amino-6-chloro-4-(methylamino)-3-pyridinecarboxylate 
• 925427-22-1 ethyl 6-chloro-4-(methylamino)-5-nitro-3-pyridinecarboxylate 
• 925546-62-9 C₁₄H₁₀ClN₃O₃ 

Downstream Products

• 925546-50-5 4-[(3-chlorophenyl)oxy]-1-methyl-7-(1-piperidinylcarbonyl)-1H-imidazo[4,5-c]pyridine 

Relevant academic research and scientific papers

COMBINATION OF CB2 LIGAND AND PARACETAMOL

Combination of one or more CB2 modulators and paracetamol are useful of treating conditions which are mediated by the activity of CB2 receptors such as an immune disorder, an inflammatory disorder, pain, rheumatoid arthritis, multiple sclerosis, osteoarthritis, and osteoporosis.

IMIDAZOPYRIDINE DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS

The present invention relates to novel imidazopyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or de